Endothelin-1 and diabetic complications

Focus on the vasculature

Adviye Ergul

Research output: Contribution to journalReview article

77 Citations (Scopus)

Abstract

Diabetes is not only an endocrine but also a vascular disease. Cardiovascular complications are the leading cause of morbidity and mortality associated with diabetes. Diabetes affects both large and small vessels and hence diabetic complications are broadly classified as microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (heart disease, stroke and peripheral arterial disease) complications. Endothelial dysfunction, defined as an imbalance of endothelium-derived vasoconstrictor and vasodilator substances, is a common denominator in the pathogenesis and progression of both macro and microvascular complications. While the pathophysiology of diabetic complications is complex, endothelin-1 (ET-1), a potent vasoconstrictor with proliferative, profibrotic, and proinflammatory properties, may contribute to many facets of diabetic vascular disease. This review will focus on the effects of ET-1 on function and structure of microvessels (retina, skin and mesenteric arteries) and macrovessels (coronary and cerebral arteries) and also discuss the relative role(s) of endothelin A (ET A) and ET B receptors in mediating ET-1 actions.

Original languageEnglish (US)
Pages (from-to)477-482
Number of pages6
JournalPharmacological Research
Volume63
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Endothelin-1
Diabetes Complications
Vasoconstrictor Agents
Diabetic Angiopathies
Mesenteric Arteries
Cerebral Arteries
Peripheral Arterial Disease
Endothelins
Microvessels
Vasodilator Agents
Vascular Diseases
Endothelium
Retina
Heart Diseases
Coronary Vessels
Stroke
Morbidity
Skin
Mortality

Keywords

  • Cerebrovasculature
  • Diabetes
  • Diabetic complications
  • Endothelial function
  • Endothelin
  • ETA receptor
  • ETB receptor
  • Peripheral vasculature
  • Retina

ASJC Scopus subject areas

  • Pharmacology

Cite this

Endothelin-1 and diabetic complications : Focus on the vasculature. / Ergul, Adviye.

In: Pharmacological Research, Vol. 63, No. 6, 01.06.2011, p. 477-482.

Research output: Contribution to journalReview article

Ergul, Adviye. / Endothelin-1 and diabetic complications : Focus on the vasculature. In: Pharmacological Research. 2011 ; Vol. 63, No. 6. pp. 477-482.
@article{05e9938caac748ee9752eefe6444d34f,
title = "Endothelin-1 and diabetic complications: Focus on the vasculature",
abstract = "Diabetes is not only an endocrine but also a vascular disease. Cardiovascular complications are the leading cause of morbidity and mortality associated with diabetes. Diabetes affects both large and small vessels and hence diabetic complications are broadly classified as microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (heart disease, stroke and peripheral arterial disease) complications. Endothelial dysfunction, defined as an imbalance of endothelium-derived vasoconstrictor and vasodilator substances, is a common denominator in the pathogenesis and progression of both macro and microvascular complications. While the pathophysiology of diabetic complications is complex, endothelin-1 (ET-1), a potent vasoconstrictor with proliferative, profibrotic, and proinflammatory properties, may contribute to many facets of diabetic vascular disease. This review will focus on the effects of ET-1 on function and structure of microvessels (retina, skin and mesenteric arteries) and macrovessels (coronary and cerebral arteries) and also discuss the relative role(s) of endothelin A (ET A) and ET B receptors in mediating ET-1 actions.",
keywords = "Cerebrovasculature, Diabetes, Diabetic complications, Endothelial function, Endothelin, ETA receptor, ETB receptor, Peripheral vasculature, Retina",
author = "Adviye Ergul",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.phrs.2011.01.012",
language = "English (US)",
volume = "63",
pages = "477--482",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Endothelin-1 and diabetic complications

T2 - Focus on the vasculature

AU - Ergul, Adviye

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Diabetes is not only an endocrine but also a vascular disease. Cardiovascular complications are the leading cause of morbidity and mortality associated with diabetes. Diabetes affects both large and small vessels and hence diabetic complications are broadly classified as microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (heart disease, stroke and peripheral arterial disease) complications. Endothelial dysfunction, defined as an imbalance of endothelium-derived vasoconstrictor and vasodilator substances, is a common denominator in the pathogenesis and progression of both macro and microvascular complications. While the pathophysiology of diabetic complications is complex, endothelin-1 (ET-1), a potent vasoconstrictor with proliferative, profibrotic, and proinflammatory properties, may contribute to many facets of diabetic vascular disease. This review will focus on the effects of ET-1 on function and structure of microvessels (retina, skin and mesenteric arteries) and macrovessels (coronary and cerebral arteries) and also discuss the relative role(s) of endothelin A (ET A) and ET B receptors in mediating ET-1 actions.

AB - Diabetes is not only an endocrine but also a vascular disease. Cardiovascular complications are the leading cause of morbidity and mortality associated with diabetes. Diabetes affects both large and small vessels and hence diabetic complications are broadly classified as microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (heart disease, stroke and peripheral arterial disease) complications. Endothelial dysfunction, defined as an imbalance of endothelium-derived vasoconstrictor and vasodilator substances, is a common denominator in the pathogenesis and progression of both macro and microvascular complications. While the pathophysiology of diabetic complications is complex, endothelin-1 (ET-1), a potent vasoconstrictor with proliferative, profibrotic, and proinflammatory properties, may contribute to many facets of diabetic vascular disease. This review will focus on the effects of ET-1 on function and structure of microvessels (retina, skin and mesenteric arteries) and macrovessels (coronary and cerebral arteries) and also discuss the relative role(s) of endothelin A (ET A) and ET B receptors in mediating ET-1 actions.

KW - Cerebrovasculature

KW - Diabetes

KW - Diabetic complications

KW - Endothelial function

KW - Endothelin

KW - ETA receptor

KW - ETB receptor

KW - Peripheral vasculature

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=79958046949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958046949&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2011.01.012

DO - 10.1016/j.phrs.2011.01.012

M3 - Review article

VL - 63

SP - 477

EP - 482

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 6

ER -